ID: ALA5172885

Max Phase: Preclinical

Molecular Formula: C24H23N5O7

Molecular Weight: 493.48

Associated Items:

Representations

Canonical SMILES:  O=c1ccn([C@@H]2O[C@H](Cn3cc(C(O)c4cccc(Oc5ccccc5)c4)nn3)[C@@H](O)[C@H]2O)c(=O)[nH]1

Standard InChI:  InChI=1S/C24H23N5O7/c30-19-9-10-29(24(34)25-19)23-22(33)21(32)18(36-23)13-28-12-17(26-27-28)20(31)14-5-4-8-16(11-14)35-15-6-2-1-3-7-15/h1-12,18,20-23,31-33H,13H2,(H,25,30,34)/t18-,20?,21-,22-,23-/m1/s1

Standard InChI Key:  FLMMNKDCCSHASQ-IBWNSAFHSA-N

Associated Targets(Human)

Beta-galactoside alpha-2,6-sialyltransferase 1 179 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 15 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 493.48Molecular Weight (Monoisotopic): 493.1597AlogP: 0.32#Rotatable Bonds: 7
Polar Surface Area: 164.72Molecular Species: NEUTRALHBA: 11HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.70CX Basic pKa: CX LogP: 0.87CX LogD: 0.87
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.28Np Likeness Score: -0.02

References

1. Dobie C, Montgomery AP, Szabo R, Yu H, Skropeta D..  (2021)  Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors.,  12  (10.0): [PMID:34778769] [10.1039/D1MD00079A]

Source